Other Briefings
India–New Zealand FTA: Financial Services Annex Unlocks Market Access for Banks, Fintech, and Digital Payments
The Financial Services Annex in the India–New Zealand FTA covers banking, insurance, fintech, digital payments, data, and back-office services, going beyond WTO GATS commitments.
India–New Zealand FTA: Business, Trade & Market Access FAQs for Exporters and Investors
This article explains how the India–New Zealand FTA affects tariffs, sector-wise exports, services trade, investment flows, visas, and regulatory compliance for businesses operating between India and New Zealand.
India’s Medical Devices Sector: PLI Progress & 2026 Outlook
India’s medical devices sector enters 2026 with strong momentum as the PLI scheme drives domestic manufacturing, exports, and investment. Explore policy progress, market outlook, and strategic opportunities for investors and global supply chains.
What is India’s FDI Outlook for 2026? Key Policy Changes, Sectors, and Trade Deals
India remains an attractive FDI destination in 2026 due to sector-specific liberalization, expanding free trade agreements, strong services and manufacturing inflows, and improved market access frameworks for foreign investors.
Managing AI Slop: Why Due Diligence is Essential for Businesses Using Generative AI
Generative AI can produce convincing but false outputs. We explain why due diligence, verification, and governance are critical to managing AI slop.
Merchant Shipping Act, 2025: Insights for Trade & Logistics Businesses
In this article, India Briefing provides an overview of the Merchant Shipping Act, 2025, outlining key regulatory reforms, expanded vessel registration, strengthened safety standards, and their commercial implications for maritime and logistics operators.
Goa: Investment Outlook amid Tourism Revival, Sector Diversification
Goa’s 2025 investment landscape reflects steady diversification beyond tourism, with new project approvals and major PPP-led infrastructure commitments. For investors, the state offers expanding opportunities across tourism-linked services and niche industrial segments.
India Opens PLI Applications for Bulk Drug Manufacturing till December 26, 2025
India has launched a fresh round of production-linked incentive (PLI) applications for essential APIs such as meropenem and ritonavir to boost bulk drug manufacturing capacity. Eligible companies can apply from November 27 to December 26, 2025.
